Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Scandinavian Candesartan Acute Stroke Trial.

Trial Profile

Scandinavian Candesartan Acute Stroke Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2015

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Cardiovascular disorders; Hypertension; Stroke
  • Focus Therapeutic Use
  • Acronyms SCAST
  • Most Recent Events

    • 04 Oct 2012 Quality-of-life outcomes presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 04 Oct 2012 Results assessing the long-term effect of treatment on cognitive function presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top